To the Editor: In July 2019, sarcopenia — a progressive and generalised skeletal muscle condition involving loss of skeletal muscle mass and function1 — was awarded a code in the International Classification of Diseases, tenth revision, Australian modification (ICD‐10‐AM). This recognition has arrived 30 years after Irwin Rosenberg first described the condition in 1989.2
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Cruz‐Jentoft AJ, Sayer AA. Sarcopenia. Lancet 2019; 393: 2636–2646.
- 2. Rosenberg IH. Summary comments. Am J Clin Nutr 1989; 50: 1231–1233.
- 3. Cruz‐Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 2010; 39: 412–23.
- 4. Cruz‐Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 16–31.
- 5. Zanker J, Scott D, Reijnierse EM, et al. Establishing an operational definition of sarcopenia in Australia and New Zealand: Delphi method based consensus statement. J Nutr Health Aging 2019; 23: 105–110.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
Jesse Zanker is supported by an Australian Government Research Training Program Scholarship. David Scott is supported by a National Health and Medical Research Council (NHMRC) RD Wright Biomedical Career Development Fellowship (GNT1123014). Sharon Brennan‐Olsen is supported by an NHMRC Career Development Fellowship (1107510).
No relevant disclosures.